CurrentAnesthesia — Cardiac arrest & resuscitation

Prevalence, Management, and Outcomes Related to Preoperative Medical Orders for Life Sustaining Treatment (MOLST) in an Adult Surgical Population: Preoperative MOLST and Code Status Discussions

2026-10-28T04:46:28.518Z

Cohort study · Ann Surg, 2020. Documented presurgery code status discussion: MOLST 169 (42.0%)

Evaluation of Use of Epinephrine and Time to First Dose and Outcomes in Pediatric Patients With Out-of-Hospital Cardiac Arrest

2026-10-28T04:44:26.953Z

Cohort study · JAMA Netw Open, 2023. Survival to hospital discharge: Epinephrine 45 (6.3%) · At-risk 29 (4.1%)

Training in Basic Life Support and Bystander-Performed Cardiopulmonary Resuscitation and Survival in Out-of-Hospital Cardiac Arrests in Denmark, 2005 to 2019

2026-10-28T04:44:26.953Z

Cohort study · JAMA Netw Open, 2023. Annual 30-day survival per 5% increase in BLS course participation rate, 30 days — BLS course participation rate +5%: OR for 30-day survival 1.14 (95% CI 1.10-1.18); P < .001; adjusted for initial rhythm, automatic external defibrillator use, and mean age

Duration of Device-Based Fever Prevention after Cardiac Arrest

2026-10-28T04:42:32.209Z

Randomised controlled trial · N Engl J Med, 2022. Composite of death from any cause or hospital discharge with Cerebral Performance Category 3 or 4 (severe cerebral disability or coma), within 90 days after randomization: 36-hour 127 (32.3%) · 72-hour 133 (33.6%)

Early Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest

2026-10-28T04:42:32.209Z

Randomised controlled trial · N Engl J Med, 2023. Survival with favourable neurologic outcome (Cerebral Performance Category 1 or 2), 30 days: Extracorporeal CPR 14 (20%) · Conventional CPR 10 (16%)

Hypothermia or Machine Perfusion in Kidney Donors

2026-10-28T04:42:32.209Z

Randomised controlled trial · N Engl J Med, 2023. Delayed graft function (initiation of dialysis during the first 7 days after transplantation), first 7 days after transplantation: Hypothermia 109 (30%) · Machine perfusion 99 (19%) · Combination therapy 103 (22%)

Epinephrine in Out-of-Hospital Cardiac Arrest: A Network Meta-analysis and Subgroup Analyses of Shockable and Nonshockable Rhythms

2026-10-28T04:40:50.491Z

Meta-analysis · Chest, 2023. ROSC — High-dose epinephrine vs Placebo or no treatment: OR for ROSC 4.27 (95% CI 3.68-4.97)

AED delivery at night – Can drones do the Job? A feasibility study of unmanned aerial systems to transport automated external defibrillators during night-time

2026-10-28T04:38:08.543Z

Research article · Resuscitation, 2023. Feasibility of night-time AED delivery: All missions completed; flights automatic without pilot interventions, apart from manually choosing landing site and correcting descent

Predictive value of soluble CD59 for poor 28-day neurological prognosis and all-cause mortality in patients after cardiopulmonary resuscitation: a prospective observatory study

2026-10-28T04:36:50.728Z

Cohort study · J Intensive Care, 2023. Prediction by serum sCD59 on day 3 after ROSC, 28 days: AUC of day-3 sCD59 for poor 28-day neurological prognosis 0.862 (95% CI 0.678-0.960)

Association between metformin and survival outcomes in in-hospital cardiac arrest patients with diabetes

2026-10-28T04:33:02.462Z

Cohort study · J Crit Care, 2022. Survival to discharge: Metformin 41.5% · No metformin 11.7%

Multimodal Prediction of Favorable Outcome After Cardiac Arrest: A Cohort Study*

2026-10-28T04:21:38.918Z

Cohort study · Crit Care Med, 2023. Prognostic performance of the multimodal score for Cerebral Performance Category (CPC) 1-2, 3 months: Sensitivity for CPC 1-2 at ≥4 of 6 points 97.5% (95% CI, 92.9-99.5%)

Time to Awakening and Self-Fulfilling Prophecies After Cardiac Arrest

2026-10-28T04:21:38.918Z

Cohort study · Crit Care Med, 2023. Prediction of awakening: Cox: mean AUC, UPMC test sets 0.93; AUC, external validation (UAB) 0.83

A randomized, double-blind trial comparing the effect of two blood pressure targets on global brain metabolism after out-of-hospital cardiac arrest

2026-10-28T04:14:48.087Z

Randomised controlled trial · Crit Care, 2023. Cerebral lactate-to-pyruvate (LP) ratio: Low MAP 19 (range 16-31) · High MAP 23 (range 16-33)

Association of ultra-early diffusion-weighted magnetic resonance imaging with neurological outcomes after out-of-hospital cardiac arrest

2026-10-28T04:14:48.087Z

Cohort study · Crit Care, 2023. Good neurological outcome, 6 months: PHSI 0; AUC for predicting poor outcome 0.87 (95% CI 0.80-0.93); Specificity 100% (95% CI 91.2%-100%); Sensitivity 74.2% (95% CI 62.0-83.5%) · AHSI 48 (75%)

Cytokine hemoadsorption with CytoSorb® in post-cardiac arrest syndrome, a pilot randomized controlled trial

2026-10-28T04:14:48.087Z

Randomised controlled trial · Crit Care, 2023. Relative reduction in IL-6 at 48 h: HA median 75% (IQR 60, 94) · SOC median 5% (IQR - 47, 70)

The effect of blood pressure on mortality following out-of-hospital cardiac arrest: a retrospective cohort study of the United Kingdom Intensive Care National Audit and Research Centre database

2026-10-28T04:14:48.087Z

Cohort study · Crit Care, 2023. Hospital mortality: Hospital mortality 56.2%

Efficacy and safety of corticosteroids in cardiac arrest: a systematic review, meta-analysis and trial sequential analysis of randomized control trials

2026-10-28T04:14:48.087Z

Meta-analysis · Crit Care, 2023. Mortality, longest point of follow-up — Corticosteroids vs Placebo or usual care: RR 0.96 (95% CI 0.90-1.02); very low certainty

Extracorporeal cardiopulmonary resuscitation for adult out-of-hospital cardiac arrest patients: time-dependent propensity score-sequential matching analysis from a nationwide population-based registry

2026-10-28T04:14:48.087Z

Cohort study · Crit Care, 2023. Good neurological recovery, discharge: ECPR 10.3% · no ECPR 6.9%

Hyperoxemia after reperfusion in cardiac arrest patients: a potential dose–response association with 30-day survival

2026-10-28T04:14:48.087Z

Cohort study · Crit Care, 2023. 30-day survival, 30 days — Mild vs Normoxemia: adjusted RR for 30-day survival 0.91 (95% CI 0.85-0.97)

Improving vasopressor use in cardiac arrest

2026-10-28T04:14:48.087Z

Research article · Crit Care, 2023. Effect of vasopressors in cardiac arrest (ROSC, 30-day survival, survival with favourable neurological outcome): Adrenaline (1 mg) highly effective at achieving ROSC (NNT 4)

Novel serum biomarkers for predicting neurological outcomes in postcardiac arrest patients treated with targeted temperature management

2026-10-28T04:14:48.087Z

Cohort study · Crit Care, 2023. Prediction of poor neurological outcome (AUC at 72 h after cardiac arrest (CA)): Tau: AUC 0.906 · NFL: AUC 0.946; sensitivity (95% CI 59.9-89.6) 77.1%; specificity 100% · GFAP: AUC 0.875 · UCH-L1: AUC 0.935

Plasma neurofilament light is a predictor of neurological outcome 12 h after cardiac arrest

2026-10-28T04:14:48.087Z

Diagnostic or prognostic study · Crit Care, 2023. Prognostic performance of NfL (AUROC) at 12 and 48 h, 12 and 48 h after cardiac arrest: OHCA: AUROC 12 h 0.93; AUROC 48 h 0.97 · IHCA: AUROC 12 h 0.81; AUROC 48 h 0.86

Prognostic models for outcome prediction following in-hospital cardiac arrest using pre-arrest factors: a systematic review, meta-analysis and critical appraisal

2026-10-28T04:14:48.087Z

Meta-analysis · Crit Care, 2023. Pooled AUROC: GO-FAR 0.78 (95% CI 0.69-0.85); AUROC 0.78 · PAM 0.59 (95% CI 0.50-0.68); AUROC 0.59 · PAR 0.62 (95% CI 0.49-0.74); AUROC 0.62

Outcomes after decrease in hypothermia usage for out of Hospital Cardiac arrest after targeted temperature management study

2026-10-28T04:08:44.882Z

Cohort study · J Clin Monit Comput, 2022. Favorable CPC outcome at hospital discharge — T33 vs T36.5: OR 2.4 (CI 1.3, 4.6); p = 0.006

Heparin Loading Dose in Patients Undergoing Extracorporeal Cardiopulmonary Resuscitation

2026-10-28T03:56:35.329Z

Cohort study · J Cardiothorac Vasc Anesth, 2023. Hemorrhagic complications: Loading-dose 75% · Nonloading-dose 67.5%

Regional Cerebral Oxygen Saturation to Predict Favorable Outcome in Extracorporeal Cardiopulmonary Resuscitation: A Systematic Review and Meta-Analysis

2026-10-28T03:56:35.329Z

Meta-analysis · J Cardiothorac Vasc Anesth, 2023. Mortality: High rSO2 98 (64.9%) · Low rSO2 87 (92.5%)

Echocardiography findings in amniotic fluid embolism: a systematic review of the literature

2026-10-28T03:51:30.684Z

Meta-analysis · Can J Anaesth, 2022. Echocardiography findings: Right ventricular (RV) dysfunction 55/82 (67%)

In-hospital cardiac arrest rhythm analysis by anesthesiologists: a diagnostic performance study

2026-10-28T03:51:30.684Z

Diagnostic or prognostic study · Can J Anaesth, 2022. Overall diagnostic performance (overall sensitivity and specificity): Median [IQR] overall sensitivity 88 [79-95]%

Accuracy of dispatch and prehospital triage performance in poisonings – A retrospective study from northern Finland

2026-10-28T03:44:37.230Z

Cohort study · Acta Anaesthesiol Scand, 2022. Recognition of poisoning: Dispatch: sensitivity 79.9% (95% CI 76.7-82.9); specificity 98.9% (95% CI 98.9-99.0)

Markers of neutrophil mediated inflammation associate with disturbed continuous electroencephalogram after out of hospital cardiac arrest

2026-10-28T03:44:37.230Z

Secondary analysis · Acta Anaesthesiol Scand, 2022. Poor grade 48-hour cEEG — Higher ICU admission osteopontin (OPN): OR 3.18 per ln[ng/ml] (95% CI 1.25-8.11); multivariable logistic regression

Veno‐arterial CO2 difference and lactate for prediction of early mortality after cardiac arrest

2026-10-28T03:44:37.230Z

Secondary analysis · Acta Anaesthesiol Scand, 2023. 96-h mortality, 96 h: ∆pCO2: AUC (95% CI) 0.59 (0.48-0.74) · Lactate: AUC (95% CI) 0.82 (0.72-0.92)

Emergency manual peri-crisis use six years following implementation: Sustainment of an intervention for rare crises

2026-10-28T03:40:44.883Z

Cohort study · J Clin Anesth, 2023. Peri-crisis EM use: Initially 145 (0.55% ± 0.045%) · One-year later 42 (0.17% ± 0.026%) · Six years post-implementation 57 (0.21% ± 0.028%)

Comparison of the Aotearoa New Zealand Early Warning Score and National Early Warning Score to predict adverse inpatient events in a vital sign dataset

2026-10-28T03:25:23.999Z

Cohort study · Anaesthesia, 2023. Any adverse outcome: New Zealand EWS: AUC 0.874 (95%CI 0.871-0.878) · UK EWS: AUC 0.874 (95%CI 0.870-0.877)

Analysis of Anxiety or Depression and Long-term Mortality Among Survivors of Out-of-Hospital Cardiac Arrest

2026-10-27T23:37:19.358Z

Cohort study · JAMA Netw Open, 2023. Long-term mortality: Depression or anxiety 141 (35.5%) · Without depression or anxiety 534 (27.0%)

Assessment of Brain Magnetic Resonance and Spectroscopy Imaging Findings and Outcomes After Pediatric Cardiac Arrest

2026-10-27T23:37:19.358Z

Cohort study · JAMA Netw Open, 2023. Unfavorable outcome at 1 year: MRI 23 (34.8%) · MRS 12 (37.5%)

Comparison of Resuscitation Quality in Simulated Pediatric and Adult Out-of-Hospital Cardiac Arrest

2026-10-27T23:37:19.358Z

Cross-sectional study · JAMA Netw Open, 2023. Defect-free care: Pediatric nonshockable 5 (12.8%) · Adult shockable 11 (28.2%) · Adult nonshockable 27 (69.2%)

Evaluation of Socioeconomic Position and Survival After Out-of-Hospital Cardiac Arrest in Korea Using Structural Equation Modeling

2026-10-27T23:37:19.358Z

Cohort study · JAMA Netw Open, 2023. Survival to discharge — NHI Q2 vs NHI Q1: aOR for survival to discharge 0.97 (95% CI 0.94-1.00)

Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest

2026-10-27T23:33:56.230Z

Cohort study · Chest, 2022. ROSC — Lidocaine vs Amiodarone: aOR for ROSC 1.15; P = .01; adjusted for all covariates

Differential Effect of Targeted Temperature Management Between 32 °C and 36 °C Following Cardiac Arrest According to Initial Severity of Illness: Insights From Two International Data Sets

2026-10-27T23:33:56.230Z

Cohort study · Chest, 2022. Favorable neurologic status by mCAHP severity tertile (subgroups), hospital discharge — TTM32-36: aOR 1.63 (95% CI 1.15-2.30); P = .006; SDEC, low severity

Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with cardiac arrest: a comparative meta-analysis and trial sequential analysis

2026-10-27T23:33:20.157Z

Meta-analysis · Lancet Respir Med, 2023. In-hospital mortality — ECPR vs CCPR: OR 0.67 (95% CI 0.51-0.87); p=0.0034; high certainty

Factors associated with circulatory death after out-of-hospital cardiac arrest: a population-based cluster analysis

2026-10-27T23:25:45.237Z

Cohort study · Ann Intensive Care, 2023. RPRS — Cluster 4: HR 5.51 (95% CI 4.51-6.74); significantly associated

The Effect of Time to Treatment With Antiarrhythmic Drugs on Survival and Neurological Outcomes in Shock Refractory Out-of-Hospital Cardiac Arrest

2026-10-27T23:20:28.165Z

Secondary analysis · Crit Care Med, 2023. Survival to hospital discharge per min of time to drug administration: Amiodarone: OR per min 0.91 (95% CI 0.90-0.93) · Lidocaine: OR 0.93 (95% CI 0.91-0.96) · Placebo: OR 0.91 (95% CI 0.90-0.93)

Hyperoxia for accidental hypothermia and increased mortality: a post-hoc analysis of a multicenter prospective observational study

2026-10-27T23:14:23.345Z

Secondary analysis · Crit Care, 2023. 28-day mortality, 28 days: Hyperoxia 25 (39.1%) · Without hyperoxia 51 (19.5%)

Prevalence, reasons, and timing of decisions to withhold/withdraw life-sustaining therapy for out-of-hospital cardiac arrest patients with extracorporeal cardiopulmonary resuscitation

2026-10-27T23:14:23.345Z

Secondary analysis · Crit Care, 2023. Prevalence, reasons and timing of WLST decisions: WLST 510 (30.7%)

Telemedical support for prehospital emergency medical service in severe emergencies: an open-label randomised non-inferiority clinical trial

2026-10-27T23:14:23.345Z

Randomised controlled trial · Crit Care, 2023. Intervention-related adverse events with suspected causality to group assignment: Primary endpoint occurred only once, in the tele-EMS group

Prehospital Extracorporeal Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrest: A Systematic Review and Meta-Analysis

2026-10-27T22:58:35.381Z

Meta-analysis · J Cardiothorac Vasc Anesth, 2022. Survival at hospital discharge (pooled, single-group): Overall survival at discharge 23.4% (95% CI 15.5-33.7)

Autoresuscitation after circulatory arrest: an updated systematic review

2026-10-27T22:52:26.060Z

Meta-analysis · Can J Anaesth, 2023. Autoresuscitation after controlled withdrawal of life-sustaining measures with or without DCD (6 observational studies): Autoresuscitation events / patients 19 / 1,049

Brain-based arterial pulse pressure threshold for death determination: a systematic review

2026-10-27T22:52:26.060Z

Meta-analysis · Can J Anaesth, 2023. Cessation of cortical scalp EEG activity after withdrawal of life-sustaining measures (one study): EEG activity fell below 2 μV when pulse pressure reached 8 mm Hg

Rationale for revisions to the definition of death and criteria for its determination in Canada

2026-10-27T22:52:26.060Z

Guideline or statement · Can J Anaesth, 2023.

Resuscitation outcomes in patients with cancer: experience in a large urban cancer centre

2026-10-27T22:52:26.060Z

Cohort study · Can J Anaesth, 2023. ICU mortality: Poor prognosis 64% · Not poor prognosis 35%